CD34 and acute myeloid leukemia: In this study, we used a previously published microarray gene expression data from nine AML patients with IDH1/IDH2 mutation and without DNMT3A mutation and eleven normal controls from normal bone marrow CD34+ hematopoietic stem and progenitor cell (HSPC) specimens23,24.